BrightSpire Capital, Inc. (BRSP)

NYSEReal EstateReit - MortgageSnapshot 2026-10-23

$3.66+0.27%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge BrightSpire Capital, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-3.7%

+10% or more+5%0%−5%−10% or less

0.66 → 0.63 EPS · FY ending Dec 31, 2027 · 5 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 5 to 5; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	83.56M
EPS	—	0.139
Annual ending 2026-12-31
Revenue	—	335.8M
EPS	—	0.541
Annual ending 2027-12-31
Revenue	—	334.23M
EPS	—	0.633

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Manage capital allocation including share repurchase and financing	It manages capital well with $250M in repurchase agreements supporting growth.	Intact	repurchase agreements fall below $200M in 2026	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 3 quarters. The company authorized a $50 million stock repurchase program in 2026-Q1 and completed its largest quarterly share buyback in 2026-Q2. These actions show active capital allocation management, delivering on stated priorities. Delivery assessment Oct 24, 2026
Maintain dividend per share at $0.16	The company maintains a steady dividend of $0.16 per share.	Intact	dividend falls below $0.16 per share next quarter	Dividend per share: $0.16 per share FY2026-Q2; GAAP. Published target: >= $0.16 dividend per share next quarter. The stored target says 2026-Q3; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Source published Jul 29, 20260.16 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 58315b8a-1774-42bf-b811-166a998d3acb. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 5 of last 5 quarters. The company consistently declared and paid a quarterly dividend of $0.16 per share from 2025-Q2 through 2026-Q2. This demonstrates management's commitment to maintaining the dividend, and the trajectory is delivering. Delivery assessment Oct 24, 2026
Grow portfolio and earnings through new loan originations	BrightSpire keeps growing its loan portfolio and earnings.	Intact	revenue falls below $83M next quarter	Revenue: $83.548M FY2026-Q2; GAAP. Published target: >= $85.14M revenue next quarter. The target does not explicitly identify fiscal versus calendar quarters. Source published Jul 29, 202683,548,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 58315b8a-1774-42bf-b811-166a998d3acb. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. The loan book grew to approximately $2.9 billion by 2026-Q2, representing over 20% year-over-year growth. Management has consistently emphasized growing the portfolio and earnings through new loan originations, and the trajectory is delivering. Delivery assessment Oct 24, 2026
Resolve remaining REO and watchlist loans	A supporting condition in BrightSpire Capital, Inc.'s published investment case. The stated target is Progress in resolving REO and watchlist loans through 2026.	Improving	No progress or increase in REO and watchlist loans by end 2026	Qualitative progress: $300M REO sale completed BrightSpire completed a $300 million sale of industrial properties, reinforcing progress in resolving REO and watchlist loans. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Management has repeatedly emphasized resolving remaining REO and watchlist loans to de-risk the portfolio. While specific resolution amounts are not quantified in the disclosures, the focus remains consistent, indicating ongoing efforts with mixed progress. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$0.63

$0.69 → $0.63 · observed estimates

FY2027 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$0.69	Unavailable	7 / 2
2026-07-25	$0.69	Unavailable	7 / 2
2026-07-26	$0.69	Unavailable	7 / 2
2026-07-27	$0.69	Unavailable	7 / 2
2026-07-28	$0.69	Unavailable	7 / 2
2026-07-29	$0.70	Unavailable	8 / 2
2026-07-30	$0.70	Unavailable	8 / 2
2026-07-31	$0.67	Unavailable	7 / 2
2026-08-01	$0.67	Unavailable	5 / 2
2026-08-02	$0.67	Unavailable	7 / 2
2026-08-03	$0.67	Unavailable	7 / 2
2026-08-04	$0.67	Unavailable	7 / 2
2026-08-05	$0.65	Unavailable	7 / 2
2026-08-06	$0.65	Unavailable	7 / 2
2026-08-07	$0.66	Unavailable	5 / 2
2026-08-08	$0.65	Unavailable	7 / 2
2026-08-09	$0.65	Unavailable	7 / 2
2026-08-10	$0.65	Unavailable	7 / 2
2026-08-11	$0.66	Unavailable	5 / 2
2026-08-12	$0.65	Unavailable	7 / 2
2026-08-13	$0.66	Unavailable	5 / 2
2026-08-14	$0.66	Unavailable	5 / 2
2026-08-15	$0.66	Unavailable	5 / 2
2026-08-16	$0.66	Unavailable	5 / 2
2026-08-17	$0.66	Unavailable	5 / 2
2026-08-18	$0.66	Unavailable	5 / 2
2026-08-19	$0.66	Unavailable	5 / 2
2026-08-20	$0.66	Unavailable	5 / 2
2026-08-21	$0.66	Unavailable	5 / 2
2026-08-22	$0.66	Unavailable	5 / 2
2026-08-23	$0.66	Unavailable	5 / 2
2026-08-24	$0.66	Unavailable	5 / 2
2026-08-25	$0.66	Unavailable	5 / 2
2026-08-26	$0.66	Unavailable	5 / 2
2026-08-27	$0.66	Unavailable	5 / 2
2026-08-28	$0.66	Unavailable	5 / 2
2026-08-29	$0.66	Unavailable	5 / 2
2026-08-30	$0.66	Unavailable	5 / 2
2026-08-31	$0.66	Unavailable	5 / 2
2026-09-01	$0.66	Unavailable	5 / 2
2026-09-02	$0.66	Unavailable	5 / 2
2026-09-03	$0.66	Unavailable	5 / 2
2026-09-04	$0.66	Unavailable	5 / 2
2026-09-05	$0.66	Unavailable	5 / 2
2026-09-06	$0.66	Unavailable	5 / 2
2026-09-07	$0.66	Unavailable	5 / 2
2026-09-08	$0.66	Unavailable	5 / 2
2026-09-09	$0.66	Unavailable	5 / 2
2026-09-10	$0.66	Unavailable	5 / 2
2026-09-11	$0.66	Unavailable	5 / 2
2026-09-12	$0.66	Unavailable	5 / 2
2026-09-13	$0.66	Unavailable	5 / 2
2026-09-14	$0.66	Unavailable	5 / 2
2026-09-15	$0.66	Unavailable	5 / 2
2026-09-16	$0.66	Unavailable	5 / 2
2026-09-17	$0.66	Unavailable	5 / 2
2026-09-18	$0.66	Unavailable	5 / 2
2026-09-19	$0.66	Unavailable	5 / 2
2026-09-20	$0.66	Unavailable	5 / 2
2026-09-21	$0.66	Unavailable	5 / 2
2026-09-22	$0.66	Unavailable	5 / 2
2026-09-23	$0.66	Unavailable	5 / 2
2026-09-24	$0.66	Unavailable	5 / 2
2026-09-25	$0.66	Unavailable	5 / 2
2026-09-26	$0.66	Unavailable	5 / 2
2026-09-27	$0.66	Unavailable	5 / 2
2026-09-28	$0.66	Unavailable	5 / 2
2026-09-29	$0.66	Unavailable	5 / 2
2026-09-30	$0.66	Unavailable	5 / 2
2026-10-01	$0.66	Unavailable	5 / 2
2026-10-02	Unavailable	Unavailable	4 / 2
2026-10-03	Unavailable	Unavailable	4 / 1
2026-10-04	Unavailable	Unavailable	4 / 1
2026-10-05	Unavailable	Unavailable	4 / 1
2026-10-06	Unavailable	Unavailable	4 / 1
2026-10-07	Unavailable	Unavailable	4 / 1
2026-10-08	Unavailable	Unavailable	4 / 1
2026-10-09	Unavailable	Unavailable	4 / 1
2026-10-10	Unavailable	Unavailable	4 / 1
2026-10-11	Unavailable	Unavailable	4 / 1
2026-10-12	Unavailable	Unavailable	4 / 1
2026-10-13	Unavailable	Unavailable	4 / 1
2026-10-14	Unavailable	Unavailable	4 / 1
2026-10-15	Unavailable	Unavailable	4 / 1
2026-10-16	Unavailable	Unavailable	4 / 1
2026-10-17	Unavailable	Unavailable	4 / 1
2026-10-18	Unavailable	Unavailable	4 / 1
2026-10-19	Unavailable	Unavailable	4 / 1
2026-10-20	Unavailable	Unavailable	4 / 1
2026-10-21	Unavailable	Unavailable	4 / 1
2026-10-22	$0.63	Unavailable	5 / 1
2026-10-23	$0.63	Unavailable	5 / 1
2026-10-24	$0.63	Unavailable	5 / 1

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Sell*
2026-05-01	6	2
2026-06-01	6	2
2026-07-01	6	2
2026-08-01	6	2
2026-09-01	6	2
2026-10-01	6	2

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 6 Buy / Strong Buy · 0 Hold · 2 Sell / Strong Sell

0 upgrades0 downgrades2 maintains

Recent actions · Sep 25–Oct 24 · 2 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

BarclaysOct 5

$4.00New observation · no comparable prior

$0$2.20$4.40

0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Manage capital allocation including share repurchase and financingDirect metric needs a verified mapping
Maintain dividend per share at $0.16Dividend per share: $0.16 per share
Grow portfolio and earnings through new loan originationsRevenue: $83.548M

Next proof point

Oct 27, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.0%Typical daily move · historical

Downside history

-40.9%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

BrightSpire Capital, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a higher-risk commercial real estate lender with a growth-and-recovery thesis, not a proven steady compounder. The long-term thesis is on watch: loan growth is progressing, while recent financial performance is weak and management execution is described as volatile.

What's priced into BrightSpire Capital, Inc.

The valuation evidence points to BRSP being cheap versus peers, with a near-zero expectations gap and medium model confidence. The priced-in tag is justified, and fragility is rated low, so the evidence does not show that the valuation case depends on unusually fragile expectations.

What the fundamentals likely do

Over the multi-year view, the loan book’s growth to about $2.9 billion by 2026-Q2 supports management’s stated goal of expanding originations and earnings. Near term, consecutive earnings misses and elevated miss risk weigh on the setup; progress resolving REO and watchlist loans is mixed, while the $0.16 quarterly dividend has been maintained through 2026-Q2. A recent share buyback announcement is positive, though a separate capital-allocation obligation was also reported.

What BrightSpire Capital, Inc. hinges on

The favorable case depends partly on lower rates or continued strength among real estate sector bellwethers, which could support the sector backdrop. The unfavorable case centers on another guidance cut, continued earnings misses, or limited progress on troubled assets. The evidence does not quantify how much the recent acquisition or new financial obligation changes the outlook.